192 Publications (Page 7 of 8)
2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs
Verheul, Henk MVerheul, HenkQian, DavidQian, DavidCarducci, Michael ACarducci, MichaelPili, Roberto and Pili, Roberto
Cancer Chemotherapy and Pharmacology, vol. 60, (no. 3), pp. 339, 20070800. | Journal Article
 
Synergistic In vivo Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination with Interleukin 2 in a Murine Model of Renal Cell Carcinoma
Kato, YukihikoYoshimura, KiyoshiShin, TahiroVerheul, HenkHammers, HansSanni, TolibSalumbides, BrendaErp, KarenSchulick, Richard and Pili, Roberto
Clinical Cancer Research, vol. 13, (no. 15), pp. 4546, 20070801. | Journal Article
 
The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-Cadherin
Kachhap, Sushant KKachhap, Sushant KKachhap, Sushant KFaith, DennisFaith, DennisDennis, FaithQian, DavidQian, David ZQian, David ZShabbeer, ShabanaShabbeer, ShabanaShabbeer, ShabanaGalloway, Nathan LGalloway, Nathan LGalloway, Nathan LPili, RobertoPili, RobertoPili, RobertoDenmeade, Samuel RDenmeade, Samuel RDenmeade, Samuel RDeMarzo, Angelo MDeMarzo, Angelo MDeMarzo, Angelo MCarducci, Michael ACarducci, Michael A and Carducci, Michael A
PloS one, vol. 2, (no. 9), pp. e844, 2007-Sep-05. | Journal Article
 
Vascular Endothelial Growth Factor Trap Blocks Tumor Growth, Metastasis Formation, and Vascular Leakage in an Orthotopic Murine Renal Cell Cancer Model
Verheul, HenkHammers, HansErp, KarenWei, YonfengSanni, TolibSalumbides, BrendaQian, DavidYancopoulos, George and Pili, Roberto
Clinical Cancer Research, vol. 13, (no. 14), pp. 4208, 20070715. | Journal Article
2006
Class II Histone Deacetylases Are Associated with VHL-Independent Regulation of Hypoxia-Inducible Factor 1α
Qian, David ZKachhap, Sushant KCollis, Spencer JVerheul, Henk M WCarducci, Michael AAtadja, Peter and Pili, Roberto
Cancer research, vol. 66, (no. 17), pp. 8821, 2006-Sep-01. | Journal Article
 
Identification of ABR‐215050 as lead second generation quinoline‐3‐carboxamide anti‐angiogenic agent for the treatment of prostate cancer
Isaacs, John TPili, RobertoQian, David ZDalrymple, Susan LGarrison, Jason BKyprianou, NatashaBjörk, AndersOlsson, Anders and Leanderson, Tomas
The Prostate, vol. 66, (no. 16), pp. 1778, 1 December 2006. | Journal Article
 
Identification of Type 1 Inosine Monophosphate Dehydrogenase as an Antiangiogenic Drug Target
Chong, Curtis RQian, David ZPan, FanWei, YongfengPili, RobertoSullivan, David J and Liu, Jun O
Journal of Medicinal Chemistry, vol. 49, (no. 9), pp. 2680, 20060504. | Journal Article
 
Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer
Carducci, MichaelCarducci, Michael ACarducci, MichaelMusib, LunaMusib, LunaMusib, LunaKies, MerrillKies, MerrillKies, Merrill SPili, RobertoPili, RobertoPili, RobertoTruong, MyleneTruong, MyleneTruong, MyleneBrahmer, Julie RBrahmer, JulieBrahmer, JulieCole, PatriciaCole, PatriciaCole, PatriciaSullivan, RanaSullivan, RanaSullivan, RanaRiddle, JeanneRiddle, JeanneRiddle, JeanneSchmidt, JillSchmidt, JillSchmidt, JillEnas, NathanEnas, NathanEnas, NathanSinha, VikramSinha, VikramSinha, VikramThornton, Donald EThornton, DonaldThornton, DonaldHerbst, RoyHerbst, Roy S and Herbst, Roy
Journal of Clinical Oncology, vol. 24, (no. 25), pp. 4099, 20060901. | Journal Article
 
Phase II Evaluation of Docetaxel Plus Exisulind in Patients With Androgen Independent Prostate Carcinoma
Sinibaldi, Victoria JSinibaldi, Victoria JElza-Brown, KathyElza-Brown, KathySchmidt, JillSchmidt, JillEisenberger, Mario AEisenberger, Mario ARosenbaum, EliRosenbaum, EliDenmeade, Samuel RDenmeade, Samuel RPili, RobertoPili, RobertoWalczak, JanetWalczak, JanetBaker, Sharyn DBaker, Sharyn DZahurak, MariannaZahurak, MariannaCarducci, Michael A and Carducci, Michael A
American journal of clinical oncology, vol. 29, (no. 4), pp. 398, 2006-Aug. | Journal Article
 
Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589
Qian, DavidQian, DavidKato, YukihikoKato, YukihikoShabbeer, ShabanaShabbeer, ShabanaWei, YongfengWei, YongfengVerheul, Hendrik MVerheul, HendrikSalumbides, BrendaSalumbides, BrendaSanni, TolibSanni, TolibAtadja, PeterAtadja, PeterPili, Roberto and Pili, Roberto
Clinical Cancer Research, vol. 12, (no. 2), pp. 642, 20060115. | Journal Article
2005
A New High Affinity Technetium-99m-Bombesin Analogue with Low Abdominal Accumulation
Lin, Kuo-ShyanLin, K-SLuu, AndrewLuu, A.Baidoo, Kwamena EBaidoo, KEHashemzadeh-Gargari, H.Hashemzadeh-Gargari, HosseinChen, M-KChen, Ming-KaiBrenneman, K.Brenneman, KennethPili, RobertoPili, RobertoPomper, Martin GPomper, MartinCarducci, Michael ACarducci, Michael AWagner, Henry N and Wagner, HN J
Bioconjugate Chemistry, vol. 16, (no. 1), pp. 50, 20050119. | Journal Article
 
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
Heath, Elisabeth IHeath, Elisabeth IGaskins, MelvinGaskins, MelvinPitot, Henry CPitot, Henry CPili, RobertoPili, RobertoTan, WinstonTan, Winston WMarschke, RobertMarschke, RobertLiu, GlennLiu, GlennHillman, DavidHillman, DavidSarkar, FazlulSarkar, FazlulSheng, ShijieSheng, ShijieErlichman, CharlesErlichman, CharlesIvy, Percy and Ivy, Percy
Clinical prostate cancer, vol. 4, (no. 2), pp. 138-141, September 2005. | Journal Article
 
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma
Wang, Xiao-FeiQian, David ZRen, MingqiangKato, YukihikoWei, YongfengZhang, LuFansler, ZoyaClark, DougNakanishi, Osamu and Pili, Roberto
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 11, (no. 9), pp. 3535, 2005-May-01. | Journal Article
 
Epigenetic Modulation of Retinoic Acid Receptor β2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell Carcinoma
Wang, Xiao-feiQian, DavidRen, MingqiangKato, YukihikoWei, YongfengZhang, LuFansler, ZoyaClark, DougNakanishi, Osamu and Pili, Roberto
Clinical Cancer Research, vol. 11, (no. 9), pp. 3535, 20050501. | Journal Article
 
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells
Qian, DavidQian, David ZRen, MingqiangRen, MingqiangWei, YongfengWei, YongfengWang, XiaofeiWang, Xiaofeivan de Geijn, Fleurvan de Geijn, FleurRasmussen, CamillaRasmussen, CamillaNakanishi, OsamuNakanishi, OsamuSacchi, NicolettaSacchi, NicolettaPili, Roberto and Pili, Roberto
The Prostate, vol. 64, (no. 1), pp. 20, 2005-Jun-15. | Journal Article
 
In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cells
Qian, David ZRen, MingqiangWei, YongfengWang, Xiaofeivan de Geijn, FleurRasmussen, CamillaNakanishi, OsamuSacchi, Nicoletta and Pili, Roberto
The Prostate, vol. 64, (no. 1), pp. 28, 15 June 2005. | Journal Article
 
Kidney cancer. Clinical practice guidelines
Motzer, Robert JMotzer, Robert JCarducci, Michael ACarducci, Michael AFishman, MayerFishman, MayerHancock, Steven LHancock, Steven LHauke, Ralph JHauke, Ralph JHudes, Gary RHudes, Gary RKantoff, PhilipKantoff, PhilipKuzel, Timothy MKuzel, Timothy MLange, Paul HLange, Paul HLevine, Ellis GLevine, Ellis GLogothetis, ChristopherLogothetis, ChrisMargolin, Kim AMargolin, KimPili, RobertoPili, RobertoPohar, Kamal SPohar, Kamal SRedman, Bruce GRedman, Bruce GRichey, SylviaRichey, SylviaRobertson, Cary NRobertson, Cary NSamlowski, Wolfram ESamlowski, Wolfram ESheinfeld, JoelSheinfeld, JoelUrban, Donald A and Urban, Donald A
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 3, (no. 1), pp. 84, 2005-Jan. | Journal Article
 
Marimastat in the Treatment of Patients with Biochemically Relapsed Prostate Cancer: A Prospective Randomized, Double-Blind, Phase I/II Trial
Rosenbaum, EliRosenbaum, EliZahurak, MariannaZahurak, MariannaSinibaldi, VictoriaSinibaldi, VictoriaCarducci, Michael ACarducci, MichaelPili, RobertoPili, RobertoLaufer, MenachemLaufer, MenachemDe Weese, Theodore LDeWeese, TheodoreEisenberger, Mario and Eisenberger, Mario A
Clinical Cancer Research, vol. 11, (no. 12), pp. 4443, 20050615. | Journal Article
 
Modeling the Cost of Management Options for Stage I Nonseminomatous Germ Cell Tumors: A Decision Tree Analysis
Link, Richard ELink, RichardAllaf, MohamadAllaf, Mohamad EPili, RobertoPili, RobertoKavoussi, Louis R and Kavoussi, Louis
Journal of Clinical Oncology, vol. 23, (no. 24), pp. 5773, 20050820. | Journal Article
2004
A New High Affinity Technetium Analogue of Bombesin Containing DTPA as a Pharmacokinetic Modifier
Lin, Kuo-ShyanLuu, AndrewBaidoo, Kwamena EHashemzadeh-Gargari, HosseinChen, Ming-KaiPili, RobertoPomper, MartinCarducci, Michael and Wagner, Henry N
Bioconjugate Chemistry, vol. 15, (no. 6), pp. 1423, 20041117. | Journal Article
 
A Phase II Trial of Temozolomide and IFN-α in Patients with Advanced Renal Cell Carcinoma
Sunkara, UshaSunkara, UshaWalczak, Janet RWalczak, Janet RSummerson, LoriSummerson, LoriRogers, TheresaRogers, TheresaEisenberger, MarioEisenberger, Mario ADenmeade, SamuelDenmeade, Samuel RPili, RobertoPili, RobertoHuff, Carol AHuff, Carol ASinibaldi, VictoriaSinibaldi, VictoriaCarducci, Michael A and Carducci, Michael A
Journal of Interferon & Cytokine Research, vol. 24, (no. 1), pp. 37-41, Jan 2004. | Journal Article
 
Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias
Karp, JudithGojo, IvanaPili, RobertoGocke, ChristopherGreer, JacquelineGuo, ChuanfaQian, DavidMorris, LawrenceTidwell, MichaelChen, Helen and Zwiebel, James
Clinical Cancer Research, vol. 10, (no. 11), pp. 3577, 20040601. | Journal Article
 
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab
Karp, Judith EKarp, Judith EGojo, IvanaGojo, IvanaPili, RobertoPili, RobertoGocke, Christopher DGocke, Christopher DGreer, JacquelineGreer, JacquelineGuo, ChuanfaGuo, ChuanfaQian, DavidQian, DavidMorris, LawrenceMorris, LawrenceTidwell, MichaelTidwell, MichaelChen, HelenChen, HelenZwiebel, James and Zwiebel, James
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 10, (no. 11), pp. 3577, 2004-Jun-01. | Journal Article
 
The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584
Qian, DavidQian, DavidWang, XiaofeiWang, XiaofeiKachhap, Sushant KKachhap, SushantKato, YukihikoKato, YukihikoWei, YongfengWei, YongfengZhang, LuZhang, LuAtadja, PeterAtadja, PeterPili, Roberto and Pili, Roberto
Cancer Research, vol. 64, (no. 18), pp. 6634, 20040915. | Journal Article
2003
CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
Ruggeri, BruceRuggeri, BruceSingh, JasbirSingh, JasbirGingrich, DianeGingrich, DianeAngeles, ThelmaAngeles, ThelmaAlbom, MarkAlbom, MarkChang, HongYang, ShiChang, HongRobinson, CandyRobinson, CandyHunter, KathrynHunter, KathrynDobrzanski, PawelDobrzanski, PawelJones-Bolin, SusanJones-Bolin, SusanAimone, LisaAimone, LisaKlein-Szanto, AndresPritchard, SonyaKlein-Szanto, AndresHerbert, Jean-MarcHerbert, Jean-MarcBono, FrancoiseBono, FrancoiseSchaeffer, PaulSchaeffer, PaulCasellas, PierreCasellas, PierreBourie, BernardBourie, BernardPili, RobertoPili, RobertoIsaacs, John TIsaacs, JohnAtor, MarkAtor, MarkHudkins, RobertHudkins, RobertVaught, JeffryMallamo, JohnMallamo, JohnDionne, CraigDionne, Craig and Vaught, Jeffrey
Cancer Research, vol. 63, (no. 18), pp. 5978, 20030915. | Journal Article